OR WAIT 15 SECS
February 23, 2021
The approval of the first-line treatment was granted to Regeneron Pharmaceuticals.
January 22, 2021
Alliance will provide insight, education, and training opportunities to pharmaceutical and life sciences professionals.
January 01, 2021
The market for acute lymphocytic leukemia and bladder cancer drug therapies is expected to soar over the next few years, thanks in part to new and innovative medications.
December 09, 2020
A new online tool allowing AllianceRx Walgreens Prime oncology patients to refill their own prescriptions saves time, while still providing pharmacists’ help when needed.
December 04, 2020
The FDA approved azacitidine tablets (Onureg; Celgene Corporation) on September 1, 2020
November 19, 2020
Gut bacteria may be partially responsible for metabolic changes that lead to weight gain following chemotherapy treatment, according to a recent study.
November 17, 2020
The phase 1b clinical trial combined olaparib with capivasertib to treat patients with germline BRCA1/2 mutations and BRCA1/2 wild-type cancers.
The FDA approved Merck's blockbuster cancer drug, pembrolizumab (Keytruda), in combination with chemotherapy, to treat locally recurrent unresectable or metastatic triple-negative breast cancer.
November 16, 2020
How community pharmacists can advance care as patients come home.
November 10, 2020
Pharmacists-in-training have a valuable impact on cancer care, according to authors of a recent journal article.
Many opportunities exist for pharmacists within the multidisciplinary care team to ensure the delivery of optimal cancer care.
October 13, 2020
The rate of prescribing opioids among both oncologists and non-oncologists has dropped significantly in the past few years.
October 12, 2020
Pharmacists are uniquely qualified to ensure patients receive sufficient pain relief.
October 05, 2020
Nivolumab plus ipilimumab decreased tumor growth in patients with untreated unresectable malignant pleural mesothelioma.
New policy recommendations aim to increase the uptake of biomarker testing and advance health insurance coverage for precision medicine in cancer care.
October 01, 2020
Investigators reported that, compared with chemotherapy, atezolizumab monotherapy was superior in overall survival and progression-free survival in patients with NSCLC.
September 11, 2020
The FDA issued a safety alert about efficacy and potential safety concerns with a combination therapy being studied for the treatment of breast cancer.
September 10, 2020
Oncology pharmacists have implemented new ways to communicate with patients, schedule visits and treatments, and re-evaluate their medications regimens during the pandemic.
September 03, 2020
There is no evidence that blood pressure lowering drugs increase the risk of cancer, according to a major new study.
Oral azacitidine (Onureg; Celgene) is approved for patients in first remission with acute myeloid leukeimia.
